PHI with Emphysematous lung
How does this condition affect your private health insurance?
“Blähungslunge,” often referring to pulmonary emphysema, is a chronic and progressive lung condition characterized by the irreversible damage and enlargement of the air sacs (alveoli) in the lungs. This destruction leads to air trapping, making the lungs hyperinflated or “bloated,” and impairs the efficient exchange of oxygen and carbon dioxide. Patients typically experience increasing shortness of breath, chronic cough, and wheezing. The primary cause is long-term exposure to irritants, predominantly cigarette smoke. Emphysema significantly reduces lung function, diminishes quality of life, and can lead to severe respiratory complications, necessitating lifelong management rather than cure.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Gradual onset over months to years, with acute exacerbations lasting days to weeks.
Duration of Illness (Lifetime)
Chronic and progressive, typically lasting decades once symptomatic.
Cost of Treatment (Initial)
Several hundred to thousands of Euros for initial diagnosis and management.
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands of Euros for lifelong management, including medications, oxygen therapy, hospitalizations, and rehabilitation.
Mortality Rate
Significant, increasing with disease severity; it is a leading cause of death worldwide.
Risk of Secondary Damages
High (e.g., respiratory failure, cor pulmonale, recurrent infections, weight loss, muscle wasting, anxiety, depression).
Probability of Full Recovery
Extremely low; lung damage is permanent, but symptoms can be managed.
Underlying Disease Risk
High (e.g., chronic bronchitis, heart disease, osteoporosis, lung cancer, diabetes, anxiety, depression).